Hot Topics: Genetics

Blog Posts (37)

March 21, 2015

Pre-Implantation Genetic Diagnosis and Abortion

The predominant purpose of pre-implantation genetic diagnosis (PGD) is to select those embryos that are considered healthy or normal. This inevitably means that those that have a genetic abnormality are discarded. Foundational to how one responds to PGD will be their understanding of the personhood of the human embryo. Often, the ethical debate is approached from the assumption that human life at this stage of... // Read More »
March 12, 2015

Taking Precautions

A common argument by ethicists concerned about the implications of bleeding-edge biotechnologies is an appeal to what is called the “precautionary principle.”  This appeal is particularly prominent on the European continent.  It attempts to raise concerns about the metaphysical, essential nature of a new technology, as opposed to the more pragmatist (and consequentialist) approach taken in Britain and the U.S.  I suppose that split should... // Read More »
March 6, 2015

“The Natural”

Saying nothing new, but trying to say it in a different way… One response to ethical problems posed by bleeding-edge biotechnologies is to assert that there are some things that ought not be attempted, some boundaries that ought never be transgressed, regardless of the supposed good that may be envisioned.  (I continue to hold that human IVF was one such boundary, but that was definitively... // Read More »
March 1, 2015

Fools Rushing In?

Trevor Stammers is our guest blogger for today.  Dr. Stammers is the Programme Director for Bioethics and Medical Law at St. Mary’s University, Twickenham in London.  Prior to St. Mary’s, he practiced as a family physician for 27 years and was a senior tutor in General Practice at St George’s, University of London.  He is also the editor for the multidisciplinary journal The New Bioethics.  Thanks... // Read More »
March 1, 2015

Fools Rushing In?

Trevor Stammers is our guest blogger for today.  Dr. Stammers is the Programme Director for Bioethics and Medical Law at St. Mary’s University, Twickenham in London.  Prior to St. Mary’s, he practiced as a family physician for 27 years and was a senior tutor in General Practice at St George’s, University of London.  He is also the editor for the multidisciplinary journal The New Bioethics.  Thanks... // Read More »
February 27, 2015

Collating Some Resources about 3-Parent IVF

With the recent news that Great Britain will indeed forge ahead with the use of nuclear transfer techniques to create “3-parent babies,” in an effort to interdict maternally-inherited mitochondrial disease, and in light of Courtney Thiele’s February 9 post on this blog (with the associated discussion), I thought it might be useful to take a moment and pull together some links to past discussions on... // Read More »
January 31, 2015

Cinematic Cautionary Tales

As a Netflix aficionado, I have seen more than my fair share of movies that are centered around the dangers of misusing biotechnologies. To the undiscerning eye, they are nothing more than thrillers or action movies with great CGI, but a more in-depth look will reveal that these films act as cautionary tales. Tales that are often ignored. I could name dozens of movies that... // Read More »
January 28, 2015

Still Alice: A Portrait of Familial Alzheimer’s Disease

by Craig M. Klugman, Ph.D.

This past weekend I spent a cold, snowy day in the theater watching the movie Still Alice.…

November 21, 2014

Bioethics Exam

In keeping with the evaluation-obsessed spirit of the time, here is a little bioethics test. No multiple-choice fill-in-the-bubbles here, no simple true/false; but bioethics usually isn’t so simple, is it? So it’s OK if you don’t have a No. 2 pencil, you can still take today’s exam! _______________________ 1. The patient-physician relationship depends on trust, and close observation, and appreciating subtleties, and giving one’s full attention... // Read More »
October 3, 2014

Prenatal Genetic Testing, and Down Syndrome

Lots of people don’t understand prenatal genetic testing, including both patients and doctors. For instance, many people think that the BUN genetic ultrasound or the “Quad screen” or the prenatal AFP tests can tell whether or not a baby has a genetic anomaly (they can’t; they can only indicate whether a fetus has an increased risk for a genetic anomaly), or that the tests are... // Read More »

View More Blog Entries

Published Articles (41)

American Journal of Bioethics: Volume 15 Issue 2 - Feb 2015

Collectivizing Rescue Obligations in Bioethics Jeremy R. Garrett

American Journal of Bioethics: Volume 14 Issue 11 - Nov 2014

Protecting Posted Genes: Social Networking and the Limits of GINA Sandra Soo-Jin Lee & Emily Borgelt

American Journal of Bioethics: Volume 14 Issue 3 - Mar 2014

Addressing the Ethical Challenges in Genetic Testing and Sequencing of Children Ellen Wright Clayton, Laurence B. McCullough, Leslie G. Biesecker, Steven Joffe, Lainie Friedman Ross, Susan M. Wolf & For the Clinical Sequencing Exploratory Research (CSER) Consortium Pediatrics Working Group

American Journal of Bioethics: Volume 14 Issue 3 - Mar 2014

Ethics and Empiricism in the Formation of Professional Guidelines Mildred K. Cho

American Journal of Bioethics: Volume 13 Issue 10 - Oct 2013

Gender Eugenics? The Ethics of PGD for Intersex Conditions Robert Sparrow

American Journal of Bioethics: Volume 13 Issue 10 - Oct 2013

Critically Appraising Prenatal Genetic Diagnosis to Prevent Disorders of Sexual Development: An Opportunity Missed Laurence B. McCullough

American Journal of Bioethics: Volume 13 Issue 5 - May 2013

The Right to Know Your Genetic Parents: From Open-Identity Gamete Donation to Routine Paternity Testing An Ravelingien & Guido Pennings

American Journal of Bioethics: Volume 13 Issue 2 - Feb 2013

Do Researchers Have an Obligation to Actively Look for Genetic Incidental Findings? Catherine Gliwa & Benjamin E. Berkman

American Journal of Bioethics: Volume 13 Issue 2 - Feb 2013

What To Do With the Could-Be-Knowns of Genomic Medicine Richard R. Sharp

American Journal of Bioethics: Volume 12 Issue 10 - Oct 2012

Review of Marion Danis, Emily Largent, David Wendler, Sara Chandros Hull, Seema Shah, Joseph Millum, Benjamin Berkman, and Christine Grady, Research Ethics Consultation: A Casebook Emily E. Anderson

View More Articles

News (799)

March 5, 2015 6:25 pm

Engineering the Perfect Baby

Can we improve the human gene pool? The position of much of mainstream science has been that such meddling would be unsafe, irresponsible, and even impossible.

February 18, 2015 3:15 pm

U.S. approves first biotech apple that resists browning

U.S. regulators on Friday approved what would be the first commercialized biotech apple, rejecting efforts by the organic industry and other GMO critics to block the new fruit.

February 9, 2015 4:07 pm

UK Set to Legalize Babies With DNA From 3 Parents

After a parliamentary vote earlier this week, the United Kingdom is set to become the first country to legalize making a baby with DNA from three parents.

January 29, 2015 2:55 pm

Obama to Request Research Funding for Treatments Tailored to Patients’ DNA

President Obama will seek hundreds of millions of dollars for a new initiative to develop medical treatments tailored to genetic and other characteristics of individual patients, administration officials say.

January 29, 2015 2:54 pm

Genetic Testing and Tribal Identity

The genetic sequencing company 23andMe recently tapped into its vast bank of data to release a study on genetic origins, producing the biggest genetic profile of the United States ever conducted—big, but nowhere near complete.

January 26, 2015 6:52 pm

Testing for mortality: Why I measured my telomeres. Should you?

This piece discusses telomere testing as a way to predict age-related diseases. Hank Greely, with the Stanford Center for Biomedical Ethics and director of Stanford’s Center for Law and the Biosciences, comments on the growing concern among federal regulators.

January 23, 2015 5:43 pm

Surprise! With $60 Million Genentech Deal, 23andMe Has A Business Plan

A deal being announced today with Genentech points the way for 23andMe, the personal genetics company backed by Facebook billionaire Yuri Milner and Google Ventures to become a sustainable business – even if the company’s discussions with the U.S. Food and Drug Administration stretch on for years.

January 23, 2015 5:42 pm

Most parents want their babies’ genome sequenced, study finds

By sequencing the billions of chemical letters in a cell’s DNA, which make up the human genome, scientists may be able to better estimate the risk of a person developing cancer, heart, biochemical and metabolic diseases.

January 16, 2015 1:02 pm

Who Owns A Human Genome?

When a human subject is involved with a scientific study, researchers must obtain informed consent, right? Well, if the study in question involves genomics research, the answer isn’t so clear.

January 9, 2015 8:29 pm

Genetic Testing Company 23andMe Finds New Revenue With Big Pharma

The past two years have been a rough and transformative time for the controversial DIY genetic testing company 23andMe. At the end of 2013, the Food and Drug Administration requested that the company shut down its main service, an analysis of a person’s genome gleaned from spit samples that anyone who purchased a kit could send in, noting that interpreting human genes—understanding what changes in DNA mean, and how they contribute or don’t contribute to disease—is still too much of a black box.

View More News Items